mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
4e-08 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
7e-07 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
1e-05 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-05 |
mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
2e-05 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |